Online CME: Hematology/Oncology
Last Updated June 3, 2009.
Special Notice!! Looking for reviewers to help keep the List up-to-date. |
The sites described on this page are primarily for hematologists and oncologists and other physicians concerned with hematology and cancer. You may find additional online CME sites and courses concerned with hematology and cancer at the main online CME site. |
Acute Myeloid Leukemia
|
After viewing this activity, you should be able to identify factors that may complicate the treatment of AML in older patients; discuss the molecular and cytogenetic pathogenesis of AML in the context of newer therapies; develop treatment strategies for patients with relapsed or refractory AML or for those with multiple co-morbidities; and apply new information on targeted therapies and “best practices” into clinical practice. |
AML Tour
(Cyberounds Acute Myeloid Leukemia in the Elderly) |
The program is in the form of a bicycle tour game. Upon completion of this activity, you should be able to discuss the incidence, prevalence and survivor rates for adult AML (acute myeloid leukemia); discuss the advantages and disadvantages of available therapies for adult AML; discuss the results of clinical trials in adult AML; describe the role of PCR and FISH in diagnosis, treatment and follow-up; and describe the mechanisms of action of potential new treatments. |
Baylor
Oncology |
Barriers to Sexual Health after Gynecologic Cancers: What Should be Done?; and Gynecologic and Colorectal Cancer: Risks and Benefits of Contraceptive Methods. |
CA - A Cancer Journal for Clinicians |
Each issue contains several articles offering 0.5 or 1.0 hours of credit. Some recent articles are: Dying, Dignity, and New Horizons in Palliative End-of-Life Care; Breast Cancer Staging; ACS Guidelines for Early Cancer Detection; Information Technology and Cancer Prevention; Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach; Staging of Non-Hodgkin Lymphoma; and Multimodality Approaches for Pancreatic Cancer. In order to take the quizzes, you must first obtain a username, password and customer number and then register with your personal information. |
Cancer Control: Journal of the Moffitt Cancer Center | This site contains full-text online versions of articles from a peer-reviewed cancer journal. Each issue focuses on one type of cancer and contains four or more major articles. A new issue comes out every two months. Currently, only one of these issues offers 2 credits of CME: Myelodysplastic Syndromes: Present Status and New Avenues to Optimize Clinical Outcomes. Each module contains a set of 20 post-test questions; you need to score at least 75% to earn credit. |
CancerNetwork.com
|
Click on CME Courses/Meetings, and register or log on to access
the instruction. There appear to be 5 kinds of activities:
|
Cleveland
Clinic Bone Marrow Failure Syndromes: Optimizing Outcomes Worldwide
|
This series was recorded during a live satellite symposium at the ASH Annual Meeting in December 2008. The goal of this series is to review the pathobiology of bone marrow disorders, describe the variations in disease patterns across global regions, and evaluate the rationale for therapies and their evidence based, clinically relevant application. |
Cleveland
Clinic Kidney Cancer Highlights
|
Lecture titles: Current Role of Cytoreductive Nephrectomy; Initial Systemic Therapy Options; Management of Small Renal Masses: The Role of Percutaneous Biopsy; and Management of Small Renal Masses: What is the Best Management Option in this Case? |
Cleveland Clinic:
Reaching New Heights: Preventing Venous Thromboembolism Throughout the
Continuum of Care |
This activity focuses on clinical practices for Venous Thromboembolism ( VTE) prophylaxis in the medical, cancer and orthopedic patient. For each type of patient you will find a didactic presentation, a case presentation and a panel discussion. |
Clinical Care Options Oncology |
About 40 text-based or case-based-interactive activities concerned with aspects of cancer. All of these categories offer CME credit: Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases. Not all activities offer CME (look for the term, "CME-certified"). |
CML Challenge (Cyberounds-Chronic
Myelegenous Leukemia) |
The Cyberounds® CML Links is an interactive golf program on new pharmacologic treatment and approaches to patients with chronic myelogenous leukemia (CML). Go to the Cyberrounds main page and click on Free CME at our CML Links to enter the program. |
Colonial Classic (Colorectal
Cancer) | The Colonial is an interactive golf game from Cyberounds. It concerns the evaluation and management of colorectal cancer with special emphasis on adjuvant chemotherapy. Upon completion of this activity you should be able to discuss the role of adjuvant chemotherapy for Stage IIB colorectal cancer; compare and contrast the types of chemotherapy for IIB; select chemotherapy for adjuvant treatment; describe the role of EGFR testing prior to use of EGFR blocking therapy; and describe the role of VEGF monoclonal antibodies in metastatic colorectal cancer. |
Continuing Cancer Education Curriculum for Health Professionals:
Human Participant Protections Education for Research Teams |
This tutorial is intended for use by those involved in the design and conduct of research involving human participants. The tutorial presents "common concepts, principles, and issues related to protection of human participants. It is intended to act as a companion piece to your institutional policy, as well as local, state, and federal regulations applicable to human research. The tutorial will help you and your team identify research activities that involve human participants, and help you understand how to protect the rights and welfare of all human participants involved in research." |
Faces of Oncology | The “Faces” series incorporates 2 case studies for each of four cancer areas: Breast Cancer; Squamous Cell Carcinoma of the Head and Neck; Non-Small Cell Lung Cancer Therapy; and Prostate Cancer Therapy. A fifth section, Gastric Cancer, is in preparation. |
Head and Neck Interventional (Cyberounds)
|
The Cyberounds® Head and Neck Interventional is an interactive program on the treatment and management of head and neck cancer. Go to the Cyberrounds main page and click on Free CME at our Head and Neck Interventional to enter the program. |
HemostasisCME.org | You will find 6 CME activities relating to hemostasis and coagulation issues: Congenital Hemophilia With Inhibitors: Treatment of Bleeding; Hemostatic Strategies in Surgery to Optimize Control of Blood Loss; Coagulation Case Challenge; Acquired Factor VIII Inhibitors: Pathophysiology and Treatment; Unexpected Bleeding Diatheses: Diagnosis and Management; and Optimizing Blood Management in Cardiovascular Surgery: Why & How. |
Hollywood Arcade (Cyberrounds -
Metastatic Breast Cancer) |
The instruction is presented in the form of a pinball game. After completing this activity, you should be able to: discuss the current management of taxane-resistant metastatic breast cancer; describe recent clinical trials involving newer taxanes and newer chemotherapy (e.g., capecitabine); describe recent clinical trials involving novel agents, e.g., epothilones, as monotherapy or in combination with capecitabine for the treatment of taxane-resistant, metastatic breast cancer; and discuss the mechanisms of action of the various proposed new agents. |
InforMEDical Oncology CME | Three programs currently offered: Advances in Treating Metastatic Bone Cancer; Advancing Treatment of Bladder Cancer; and Novel Agents in the Treatment of Lung Cancer: Assessing Opportunities for Combination Therapy. |
Medscape
Hematology-Oncology
|
CME activities of special interest to hematologists and oncologists. Medscape
contains a variety of educational formats:
|
MelanomaCare.org |
You will find 10 webcasts/podcasts; the newest are: Melanoma: A Mysterious Disease?; Scientific and Clinical Interpretation of New Data on IFN-a for Adjuvant Therapy of Melanoma; Signal Transduction Inhibitors in Melanoma; Update on histologic and molecular markers for melanoma;
and Optimizing imaging studies for baseline assessment and surveillance of melanoma.
You will also find 5 text publications on various aspects of melanoma
management. You must fax or mail completed test questions in order to receive
CME credit. |
Meniscus
Limited
|
There are 4 activities at this time: CINV (chemotherapy-induced nausea and vomiting): Using Evidence-Based Practice to Improve Patient Outcomes; Critical Decision Making in Health Care-Associated Infections: Managing Serious Pediatric Infections; Systemic Chemotherapy for Breast Cancer: Issues in Preoperative and Adjuvant Treatment; and Special Report: Supportive Care Issues in Cancer No. 2. |
The Oncologist | "Over 195" courses in a wide variety of hematology and oncology areas. Some major areas are: Acute and Chronic Leukemias and Multiple Myeloma; Breast Cancer; Cancer Biology; Clinical Pharmacology; Gastrointestinal Cancer; Genitourinary Cancer; Lung Cancer; Lymphoma; Radiation Oncology; Schwartz Center Rounds; and Symptom Management and Supportive Care. |
Oncology E-Learning Center (formerly Imedex) |
A variety of courses in oncology. Topics covered are: Breast, Gastrointestinal, General Oncology, Genitourinary, Hematology, Lung and Melanoma. |
OnsiteInsight |
There are currently 2 issues of OnsiteInsight. The latest issue covers topics coming out the recent European Society of cardiology, held in September 2008. The previous issue covers the American College of Cardiology (ACC) Scientific Sessions in April 2008. Both concern platelets and clotting issues. |
OptumHealth Education |
The slide-video lectures currently available are in the following areas: Cardio (6), Infectious Disease (3), Gastroenterology (1), Neuroscience (32), and Oncology (9). |
Projects in
Knowledge Advanced Certificate Program: Breast Cancer Management |
This yearlong, 19-course curriculum (11.25 CME Credits) will offer practical discussions about diagnostic techniques, methodologies, and treatment options in your care of patients with breast cancer. One or two new activities is presented each month. |
Projects In Knowledge Advanced Certificate Program IV: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
|
The fourth year of this program features 19 courses presented online over one year, and offers up to 18 credits. The curriculum contains the latest information on HBV virology and genotyping, screening and diagnosis in the Asian community, AASLD, Keeffe, and APASL hepatitis B virus treatment guidelines, and current and emerging treatment strategies. It will also help clinicians understand the impact of cultural differences in the management of HBV infection, with particular focus on the Asian and Pacific Islander communities. |
Projects
in Knowledge Advanced Certificate Program: Lung Cancer Management |
This 12-month curriculum explores both non-small-cell lung cancer (NSCLC) as well as small cell lung cancer (SCLC) with respect to Guidelines, Assessing at-risk individuals, Screening, Diagnosis, Staging and Treatment. Current and emerging innovative treatment options and strategies in lung cancer are emphasized, such as chemotherapy (including newer agents such as paclitaxel, pralatrexate and talotrexin), chemoradiation, neoadjuvant and adjuvant chemotherapy), consolidative chemotherapy, targeted therapies (including vascular endothelial growth factor [VEGF] inhibitors, epidermal growth factor [EGFR] inhibitors, matrix metalloprotease (MMP) inhibitors, farnesyl transferase [FT] inhibitors, multikinase inhibitors, inhibitors of Ras, HDAC, mTOR, Met, MEK, toll and p13K, that include gefitinib, erlotinib, bevacizumab, sunitinib, sorafenib, lonafarnib, vandetanib and cetuximab). |
Projects In Knowledge Caring for Oncology Patients: Tips and Tools for Managing Targeted Therapy
|
These activities examine strategies for treating, monitoring, and managing side effects in cancer patients on targeted agents. After concluding this series, you will be able to assess the molecular basis of targeted therapy side effects, differentiate between side effects of traditional oncology therapies vis-á-vis targeted therapies, and evaluate treatment regimens for preventing and managing side effects of targeted therapies. This series began in April 2008. The first 3 activities are already posted (6/15/08); the other 9 will be posted as the year goes on. |
Projects
in Knowledge: The Art of Individualized Treatment in the Management of Colorectal Cancer
|
Three speakers explore the state of the science in colorectal cancer (CRC). Using the backdrop of a case study, the experts delve into the underlying mechanisms of oncogenesis, including key signaling pathways leading to tumorigenesis. The program offers you the opportunity to consider individualized treatment options, such as combination targeted-therapy regimens, as alternatives to FOLFOX and monotherapy, as well as the importance of diet and lifestyle issues for patients with CRC. |
SCACO - Southern California Academy of Clinical
Oncology
|
On 12/31/08, this message was presented at the site: "ACO is down for maintenance and will back online soon." |
Texas Medical Association’s Physician Oncology Education Program (POEP) | The five activities are: Ovarian Cancer: Designed for the Primary Care Physician (1.0 hour); Pain Primer for Primary Physicians (1.5 hours); Performance Improvement (PI) Continuing Medical Education Project for Primary Care Physicians (20 hours); Survivorship (Lance Armstrong Foundation: Professional Training Opportunities) (hours not stated); and Tobacco Intervention and the Health Care Provider (1.0 hour). |
TumorAblationClinic.com
|
Four articles on the use of radiofrequency (RFA) and cryoablation in the treatment of various tumors: RFA and cryoablation offer safe, effective treatment of bone tumors; Ablation of kidney tumors can treat nonsurgical candidates; RFA in lung cancer: promising results in safety and efficacy; and Expanded treatment of hepatic tumors is possible with RFA and cryoablation. Read all 4 articles before taking the test for CME credit (4 hours). |
University of Colorado Cancer Center: Hematological Malignancies
|
Fundamental Management modules are designed for primary care physicians, physicians’ assistants, nurses, and pharmacists. Recent Advances Including Novel Therapies modules are designed for Hematology/Oncology physicians. Topics include: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Myeloid Leukemia; Diffuse Large B-cell Lymphoma; Follicular Lymphoma; Hodgkin's Lymphoma; Myeloproliferative Disorders; Plasma Cell Disorders; Multiple Myeloma and Other Plasma Cell Disorders; Myelodysplastic Syndrome; and Bone Marrow Transplant. |